Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones

Abstract To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best...

Full description

Bibliographic Details
Main Authors: Arshia Hashemi, Milad Noori, Navid Dastyafteh, Seyed Esmaeil Sadat-Ebrahimi, Negin Fazelzadeh Haghighi, Katayoun Mehrpour, Elahe Sattarinezhad, Fatemeh Jalali Zafrei, Cambyz Irajie, Mohammad Ali Daneshmehr, Majid Heydari, Bagher Larijani, Aida Iraji, Mohammad Mahdavi
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Chemistry
Subjects:
Online Access:https://doi.org/10.1186/s13065-023-00978-3
_version_ 1827917202031902720
author Arshia Hashemi
Milad Noori
Navid Dastyafteh
Seyed Esmaeil Sadat-Ebrahimi
Negin Fazelzadeh Haghighi
Katayoun Mehrpour
Elahe Sattarinezhad
Fatemeh Jalali Zafrei
Cambyz Irajie
Mohammad Ali Daneshmehr
Majid Heydari
Bagher Larijani
Aida Iraji
Mohammad Mahdavi
author_facet Arshia Hashemi
Milad Noori
Navid Dastyafteh
Seyed Esmaeil Sadat-Ebrahimi
Negin Fazelzadeh Haghighi
Katayoun Mehrpour
Elahe Sattarinezhad
Fatemeh Jalali Zafrei
Cambyz Irajie
Mohammad Ali Daneshmehr
Majid Heydari
Bagher Larijani
Aida Iraji
Mohammad Mahdavi
author_sort Arshia Hashemi
collection DOAJ
description Abstract To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencies with an IC50 value of 34.67 ± 3.68 µM. The kinetic evaluations of 9q as the most potent derivatives recorded mix-type inhibition. Compounds 9o and 9q also exhibited potent antioxidant capacity with IC50 values of 38.81 and 40.73 µM, respectively confirming their antioxidant potential. Molecular docking studies of 9q as the most potent derivative were exacuated and it was shown that quinazolinone and acetamide moieties of compound 9q participated in interaction with critical His residues of the binding site. The obtained results demonstrated that the 9q can be considered a suitable pharmacophore to develop potent tyrosinase inhibitors.
first_indexed 2024-03-13T03:24:26Z
format Article
id doaj.art-a24627d932c144e285bc18cb67be1ce7
institution Directory Open Access Journal
issn 2661-801X
language English
last_indexed 2024-03-13T03:24:26Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Chemistry
spelling doaj.art-a24627d932c144e285bc18cb67be1ce72023-06-25T11:07:56ZengBMCBMC Chemistry2661-801X2023-06-0117111110.1186/s13065-023-00978-3Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinonesArshia Hashemi0Milad Noori1Navid Dastyafteh2Seyed Esmaeil Sadat-Ebrahimi3Negin Fazelzadeh Haghighi4Katayoun Mehrpour5Elahe Sattarinezhad6Fatemeh Jalali Zafrei7Cambyz Irajie8Mohammad Ali Daneshmehr9Majid Heydari10Bagher Larijani11Aida Iraji12Mohammad Mahdavi13Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesDepartment of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical SciencesMolecular Dermatology Research Center and Department of Dermatology, Shiraz University of Medical SciencesStem Cells Technology Research Center, Shiraz University of Medical SciencesDepartment of Pharmacology, School of Medicine, Shiraz University of Medical SciencesCardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical SciencesDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical SciencesDepartment of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical SciencesStudent Research Committee, Shiraz University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesStem Cells Technology Research Center, Shiraz University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesAbstract To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencies with an IC50 value of 34.67 ± 3.68 µM. The kinetic evaluations of 9q as the most potent derivatives recorded mix-type inhibition. Compounds 9o and 9q also exhibited potent antioxidant capacity with IC50 values of 38.81 and 40.73 µM, respectively confirming their antioxidant potential. Molecular docking studies of 9q as the most potent derivative were exacuated and it was shown that quinazolinone and acetamide moieties of compound 9q participated in interaction with critical His residues of the binding site. The obtained results demonstrated that the 9q can be considered a suitable pharmacophore to develop potent tyrosinase inhibitors.https://doi.org/10.1186/s13065-023-00978-3IsopropylquinazolinoneSynthesiseTyrosinaseEnzyme inhibitionKinetic evaluationIn silico studies
spellingShingle Arshia Hashemi
Milad Noori
Navid Dastyafteh
Seyed Esmaeil Sadat-Ebrahimi
Negin Fazelzadeh Haghighi
Katayoun Mehrpour
Elahe Sattarinezhad
Fatemeh Jalali Zafrei
Cambyz Irajie
Mohammad Ali Daneshmehr
Majid Heydari
Bagher Larijani
Aida Iraji
Mohammad Mahdavi
Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
BMC Chemistry
Isopropylquinazolinone
Synthesise
Tyrosinase
Enzyme inhibition
Kinetic evaluation
In silico studies
title Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
title_full Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
title_fullStr Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
title_full_unstemmed Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
title_short Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
title_sort synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
topic Isopropylquinazolinone
Synthesise
Tyrosinase
Enzyme inhibition
Kinetic evaluation
In silico studies
url https://doi.org/10.1186/s13065-023-00978-3
work_keys_str_mv AT arshiahashemi synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT miladnoori synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT naviddastyafteh synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT seyedesmaeilsadatebrahimi synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT neginfazelzadehhaghighi synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT katayounmehrpour synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT elahesattarinezhad synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT fatemehjalalizafrei synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT cambyzirajie synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT mohammadalidaneshmehr synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT majidheydari synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT bagherlarijani synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT aidairaji synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones
AT mohammadmahdavi synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones